Risk and Benefit Informed MTM Pharmacist Intervention in Heart Failure
Heart Failure
About this trial
This is an interventional health services research trial for Heart Failure focused on measuring Heart Failure, Machine Learning, Medication Therapy Management, Supervised Machine Learning, Population Health Management
Eligibility Criteria
Inclusion Criteria:
- All adult Geisinger patients with heart failure, as identified by a validated EHR (Electonic Health Record)-based phenotype algorithm,
- Patients with a Geisinger primary care provider (PCP)
- Patients who follow with Geisinger Cardiology (at least 1 visit in past two years).
- Fulfills the specifications for arm assignment based on the results of the care gap benefit model.
Exclusion Criteria:
- Patients with a Geisinger PCP or Cardiologist in the South Central Region (part of the Geisinger Holy Spirit footprint) as MTM availability is limited in this service area.
- Patients who have indicated they do not wish to participate in research studies
Sites / Locations
- Geisinger Health System
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
No Intervention
Active Comparator
High benefit, MTM
High benefit, no MTM
Low benefit, MTM
This arm will comprise patients with heart failure who are predicted to receive high benefit (reduction in mortality risk) by addressing open care gaps. Following randomization, they will be referred to MTM pharmacy for review of treatments in an attempt to close appropriate care gaps.
This arm will comprise patients with heart failure who are predicted to receive high benefit (reduction in mortality risk) by addressing open care gaps. Following randomization, they will continue to receive clinical standard-of-care: regular follow-ups with Community Medicine (every 3 months) and Cardiology (every six months). Importantly, these individuals are eligible for referral to MTM at the discretion of their physicians.
This arm will comprise patients with heart failure who are predicted to receive low benefit (reduction in mortality risk) by addressing open care gaps. They will be selected based on age, sex, and risk-matching to the High benefit, MTM arm. They will be referred to MTM pharmacy for review of treatments in an attempt to close appropriate care gaps.